---
schema_version: "secwatch.filing_event.v1"
accession: "0001549084-22-000080"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2022-12-09T23:59:59+00:00"
generated_at: "2026-06-21T06:47:58.504015+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics appoints CEO Scott G. Davis to its Board of Directors

## Summary
- Appointment effective Dec 8, 2022; term expires at 2023 Annual Meeting.
- Davis previously served as President and COO before becoming CEO.
- No arrangements or understandings with any person for his board election.
- No family relationships or material interest in reportable transactions.

## SEC filing metadata
- accession: 0001549084-22-000080
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2022-12-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000154908422000080/0001549084-22-000080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000154908422000080/ekso-20221208.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001549084-22-000080
- JSON: https://secwatch.observer/filing/0001549084-22-000080.json
- Plain text: https://secwatch.observer/filing/0001549084-22-000080.txt

## Key facts
- Executive change
  Scott G. Davis was appointed as Director at EKSO BIONICS HOLDINGS, INC..
  - Action: appointed
  - Role: Director
  source text: On December 8, 2022, effective immediately, the Board of Directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”) appointed Scott G. Davis to serve as a director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000154908422000080/0001549084-22-000080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.